A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells
about
Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancersDNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancersCrystal structures of the heparan sulfate-binding domain of follistatin. Insights into ligand bindingTENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independenceAndrogen signaling promotes translation of TMEFF2 in prostate cancer cells via phosphorylation of the α subunit of the translation initiation factor 2TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including gliomaInsights into the evolution of the ErbB receptor family and their ligands from sequence analysisIdentification of differentially expressed genes associated with androgen-independent growth of prostate cancer.Obligate multivalent recognition of cell surface tomoregulin following selection from a multivalent phage antibody library.Tomoregulin internalization confers selective cytotoxicity of immunotoxins on prostate cancer cells.The process-inducing activity of transmembrane agrin requires follistatin-like domainsTmeff2 is expressed in differentiating oligodendrocytes but dispensable for their differentiation in vivoGene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma.Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum.Global gene analysis of oocytes from early stages in human folliculogenesis shows high expression of novel genes in reproduction.The epidermal growth factor receptor family: biology driving targeted therapeutics.Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands.Hypermethylation of the TPEF/HPP1 gene in primary and metastatic colorectal cancers.Tomoregulin-1 prevents cardiac hypertrophy after pressure overload in mice by inhibiting TAK1-JNK pathways.Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.Analysis of TMEFF2 allografts and transgenic mouse models reveals roles in prostate regeneration and cancer.ErbB receptors and epithelial-cadherin-catenin complex in human carcinomas.TMEFF2 modulates the AKT and ERK signaling pathwaysRole of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders.TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.An evolving web of signaling networks regulated by Cripto-1.Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseasesThe multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.Tomoregulin (TMEFF2) Binds Alzheimer's Disease Amyloid-β (Aβ) Oligomer and AβPP and Protects Neurons from Aβ-Induced Toxicity.The interplay between histone deacetylases and c-Myc in the transcriptional suppression of HPP1 in colon cancer.The tumor suppressor activity of the transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) correlates with its ability to modulate sarcosine levels.Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17.TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells.Generation and characterization of Tmeff2 mutant miceThe Tumor Suppressive Effects of HPP1 Are Mediated Through JAK-STAT-Interferon Signaling Pathways.ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease.Follistatin: essential role for the N-terminal domain in activin binding and neutralization.Vascular genomics of the human brain.TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer.
P2860
Q22000749-19CE0EAA-4AA2-4C57-A7FE-7A38C7FEEDF3Q24546185-C743B99C-1504-41E7-B54F-D7FB6349B8F2Q24650975-CA0BBC5D-9C8D-4229-887E-517E9DCE1405Q27641689-EBF16843-AD2E-4B99-B536-9E71013A78B8Q28201559-F87AA34F-8969-40D7-8933-C4B880877538Q28486024-7122CDFC-F9A8-47B7-BBF3-9E2C8767DF3AQ28740616-37FBC17C-AE42-4246-A1E3-74F7EAF46207Q28767062-8BDE5ABB-625F-4ACD-AC8A-0BB405302664Q30835299-AB17F8ED-2D1A-44B0-B7A3-2E99AD3E2886Q33263079-42DD150F-0C09-4A12-9107-13C91FA0FCC8Q33352471-FAA8C33F-D432-4197-B252-49952F435551Q33661617-F7D2AB6F-2CE1-4A55-9DA5-152C62C5BED4Q33671731-FF1F057B-E63F-457A-A86F-8DDFD50BD7ABQ33691683-6A8A0C40-7512-490B-88BA-5A8309D14D49Q34049950-A28A708D-8E4B-4D95-9229-9CD5065BA174Q34124869-4C2460E8-DF90-463F-A1AA-F3A40F65E9F5Q34692233-7E676795-60DB-4FDF-B5C3-5D3F300372EBQ34749765-2B404AB7-70D4-4FEA-A881-AC7920450AD7Q34769653-FDA17EA1-ECD8-4327-B8DF-40141AFBF83AQ35923510-703E15BC-B4AB-472F-9E50-28CD6BEC9D98Q36241244-2697DCA2-3FB6-4EE2-A848-90224909831DQ36490023-64C9D060-0BE1-45A8-9EE8-FD69C43CBEFEQ36677496-DB8A8932-BB07-47B9-BE21-F908FBFEEC40Q37059535-71132882-2978-4E0E-A2AE-2EF450CFAF71Q37391177-91892041-FE22-4B7D-B75D-E2DB857E61CEQ37426032-1EA27C71-3D52-40DA-B780-1521EBA832F1Q37965746-7F4F11CE-2825-476D-818C-F3AE49A5B4E6Q38225912-FC273E61-88AB-43A4-91EB-CD1BD4CE7BB9Q38242892-0296413A-3B50-4934-87B7-96FEEAFCD213Q38832899-265C1CDC-1A6C-40F8-9A43-07779A3A48A5Q38985848-077B041A-BB9D-456D-8E95-DA974425EE00Q39577910-33173ED0-390A-43A6-96B3-CDE391ACDC5CQ40066641-203EBE41-7904-411B-825B-8FD0FBE89FCEQ40720226-E88E364E-66AD-4162-B76B-2E1779F3B9B7Q42321417-3372F77C-4B4F-45E9-A191-4463B759CCF8Q42412048-24E968DA-657F-4C55-B405-312275DBF7AAQ43248887-E247451F-D52B-4202-B6F1-048839DD575AQ43560314-ABB22D33-3246-438D-A6AC-B99C84221C19Q46466504-B2F241BD-4425-48D2-ABFC-7484F74E17C8Q48005105-419714E4-37A3-4BA5-9CDB-E777FE0881F7
P2860
A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells
description
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
im Dezember 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 20 December 1999)
@en
vedecký článok (publikovaný 1999/12/20)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/12/20)
@nl
наукова стаття, опублікована в грудні 1999
@uk
научни чланак (објављен 1999/12/20)
@sr
name
A novel epidermal growth facto ...... in MKN28 gastric cancer cells
@ast
A novel epidermal growth facto ...... in MKN28 gastric cancer cells
@en
A novel epidermal growth facto ...... in MKN28 gastric cancer cells
@nl
type
label
A novel epidermal growth facto ...... in MKN28 gastric cancer cells
@ast
A novel epidermal growth facto ...... in MKN28 gastric cancer cells
@en
A novel epidermal growth facto ...... in MKN28 gastric cancer cells
@nl
prefLabel
A novel epidermal growth facto ...... in MKN28 gastric cancer cells
@ast
A novel epidermal growth facto ...... in MKN28 gastric cancer cells
@en
A novel epidermal growth facto ...... in MKN28 gastric cancer cells
@nl
P2093
P356
P1476
A novel epidermal growth facto ...... in MKN28 gastric cancer cells
@en
P2093
A Mizoguchi
C Sakamoto
M Yonezawa
T Akamatsu
P304
P356
10.1006/BBRC.1999.1873
P407
P577
1999-12-20T00:00:00Z